Skip to content
Riskpilot
← Back to search
Sign in
Get full access
COVIDIEN DANMARK ApS
APS
Dissolved
Advertising protection
CVR 26819601
Arne Jacobsens Allé 17, 2300
København S
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2002 · 23 years old
23 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
COVIDIEN DANMARK ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
61M
121M
182M
243M
204M
2013
211M
2014
0M
2015
EBITDA
DKK millions
20M
15M
10M
5M
0M
16M
2013
4M
-75%
2014
0M
-100%
2015
Income statement
DKK thousands
Item
2013
2014
2015
Revenue
204.437
211.054
214
Staff expenses
-0
-0
-0
EBITDA
15.767
3.967
7
Depreciation & amort.
-0
-0
-0
EBIT
15.767
3.967
7
Net financials
-244
371
-0
Profit before tax
15.523
4.338
7
Tax
5.301
404
2
Net profit
10.222
3.934
5
Balance sheet
DKK thousands
Item
2013
2014
2015
Total assets
89.763
90.238
91
Equity
40.334
44.268
49
Long-term debt
0
0
0
Short-term debt
49.429
45.970
42
Total debt
49.429
45.970
42
Financial ratios
5-year trend
EBITDA margin
3.2%
This company
15.8%
Market median
-80% vs market
2013
2015
Equity ratio
54.0%
This company
38.2%
Market median
+41% vs market
2013
2015
Return on equity
9.8%
This company
18.4%
Market median
-47% vs market
2013
2015
Net profit margin
2.2%
This company
8.1%
Market median
-73% vs market
2013
2015
Asset turnover
2.35×
This company
1.12×
Market median
+110% vs market
2013
2015
Debt / equity
0.85×
This company
0.62×
Market median
+37% vs market
2013
2015
Annual reports & filings
Annual report 2015
Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
View
PDF
Annual report 2014
Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
View
PDF
Annual report 2013
Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
View
PDF
More on COVIDIEN DANMARK ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
